Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
